Literature DB >> 8916706

Cost effectiveness of lowering cholesterol. Cost consequence analysis may be more useful to decision makers.

J Shepherd.   

Abstract

Entities:  

Mesh:

Year:  1996        PMID: 8916706      PMCID: PMC2352419          DOI: 10.1136/bmj.313.7065.1142

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: life table method applied to health authority population.

Authors:  P D Pharoah; W Hollingworth
Journal:  BMJ       Date:  1996-06-08

2.  Long-term prognosis of different forms of coronary heart disease: the Reykjavik Study.

Authors:  E Sigurdsson; N Sigfusson; U Agnarsson; H Sigvaldason; G Thorgeirsson
Journal:  Int J Epidemiol       Date:  1995-02       Impact factor: 7.196

3.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

4.  Measuring quality of life in patients with myocardial infarction or stroke: a feasibility study of four questionnaires in The Netherlands.

Authors:  M C Visser; P J Koudstaal; R A Erdman; J W Deckers; J Passchier; J van Gijn; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  1995-10       Impact factor: 3.710

  4 in total
  1 in total

1.  A cost-consequences analysis of a primary care librarian question and answering service.

Authors:  Jessie McGowan; William Hogg; Jianwei Zhong; Xue Zhao
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.